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Abstract
Background: Euploid chromosome balance is vitally important for normal development, but is profoundly changed in
many tumors. Is each tumor dependent on its own structurally and numerically changed chromosome complement that
has evolved during its development and progression?
We have previously shown that normal chromosome 3 transfer into the KH39 renal cell carcinoma line and into the
Hone1 nasopharyngeal carcinoma line inhibited their tumorigenicity. The aim of the present study was to distinguish
between a qualitative and a quantitative model of this suppression. According to the former, a damaged or deleted tumor
suppressor gene would be restored by the transfer of a normal chromosome. If so, suppression would be released only
when the corresponding sequences of the exogenous normal chromosome are lost or inactivated. According to the
alternative quantitative model, the tumor cell would not tolerate an increased dosage of the relevant gene or segment.
If so, either a normal cell derived, or, a tumor derived endogenous segment could be lost.
Methods: Fluorescence in Situ Hybridization based methods, as well as analysis of polymorphic microsatellite markers
were used to follow chromosome 3 constitution changes in monochromosomal hybrids.
Results: In both tumor lines with introduced supernumerary chromosomes 3, the copy number of 3p21 or the entire
3p tended to fall back to the original level during both in vitro and in vivo growth. An exogenous, normal cell derived, or
an endogenous, tumor derived, chromosome segment was lost with similar probability. Identification of the lost versus
retained segments showed that the intolerance for increased copy number was particularly strong for 3p14-p21, and
weaker for other 3p regions. Gains in copy number were, on the other hand, well tolerated in the long arm and
particularly the 3q26-q27 region.
Conclusion: The inability of the cell to tolerate an experimentally imposed gain in 3p14-p21 in contrast to the well
tolerated gain in 3q26-q27 is consistent with the fact that the former is often deleted in human tumors, whereas the
latter is frequently amplified. The findings emphasize the importance of even minor changes in copy number in seemingly
unbalanced aneuploid tumors.
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Background
Euploid chromosome balance is vitally important for nor-
mal development. Changes in autosomal copy number
are lethal or lead to serious developmental anomalies.
Normal human cells tend to maintain a diploid chromo-
some complement in culture. Cancer cells are aneuploid,
as a rule. This has been interpreted in different ways dur-
ing the history of cancer cytogenetics. T. Boveri has pro-
posed in 1914 that all tumors are due to chromosomal
changes. Extensive examination of cancer chromosomes
in the first half of the 20th century by the crude cytogenet-
ical methods that were available gave a picture of total dis-
order. This has led to the view that aneuploidy is a
consequence rather than a cause of cancer development.
More discriminating cytogenetic and molecular tech-
niques detected an increasing number of specific tumor-
associated chromosomal changes during subsequent
years, but the broadly variable background was still
regarded as non-specific "noise". More recent technolo-
gies, particularly Spectral Karyotyping (SKY) and Compar-
ative Genomic Hybridization (CGH) identified an
increasing number of repeatedly occurring, tumor type
specific chromosomal segment changes that were not
apparent on ordinary cytogenetic examination. It may be
therefore questioned whether any recurrent change can be
dismissed as noise. Given the dynamics of tumor cell
growth and the plasticity of the karyotype, it is conceiva-
ble that all persisting aberrations may have a selective
value.
In the present study we have asked whether the copy
number of a given chromosomal segment may be criti-
cally important for the growth of an aneuploid tumor, so
that no quantitative changes would be tolerated. Are some
chromosome segments prone to losses and others to gains
in a functionally relatable fashion?
It is known that the short arm of chromosome 3 is fre-
quently deleted, while 3q is often amplified in variety of
human tumors [1,2]. In order to examine whether the
equilibrium of a certain chromosome 3 (chr3) segment
copy number is critical for an aneuploid tumor, we have
introduced one or two supernumerary chrs3 by microcell
mediated chromosome transfer into two different carci-
noma lines, the nonpapillary renal cell carcinoma (RCC)
derived KH39 and the nasopharyngeal carcinoma (NPC)
derived Hone1. Both tumor types are characterized by fre-
quent chr3 changes that lead to 3p losses and 3q gains [3-
5]. KH39 is hyper-diploid with few chromosomal anom-
alies, it carries two morphologically normal chrs3 [6].
Hone1 is hypo-tetraploid with a large number of segmen-
tal imbalances. Chr3 is rearranged and participates in 8
markers [7]. Deletions, duplications and imbalanced
translocations resulted in very complex picture of segmen-
tal imbalances along the chr3 in Hone1 (our unpublished
data). Importantly for us, 3p was involved in losses, while
3q in gains.
Using these cell lines we have previously shown that the
introduction of a normal chr3 inhibited tumor growth
[7,8]. Analysis of the tumors derived from the KH39 back-
ground microcell hybrids (MCHs) identified regular
losses affecting the 3p14.3-p21.3 region [8]. The deleted
regions corresponded to or overlapped with the Common
Eliminated Region 1 (CER1) and the Frequently Elimi-
nated Region (FER), previously defined through their
elimination from human chr3 mouse fibrosarcoma
MCHs during in vivo growth [9-11]. The 3p21.3 region
was also shown to be important for chr3 transfer medi-
ated tumor suppression in Hone1 based MCHs [7]. This
was taken to suggest that 3p21 harbors tumor suppressor
gene(s) (TSG) that are deleted or inactivated in the
tumors. Normal chr3 transfer would inhibit tumor
growth by restoring the missing function. If so, the loss of
relevant TSGs from the normal exogenous chr3 could
release the suppression [12]. Our findings did not confirm
this expectation in KH39 derived MCHs [8]. Regular loss
of supernumerary 3p copies from the MCHs after tumor
growth was not necessarily accompanied by loss of heter-
ozygosity (LOH), expected if the "TSG loss" model is valid
(figure 1A). The alternative "mandatory chromosomal
segment copy number" hypothesis (figure 1B) implies
that the tumor karyotype is finely tuned with regard to the
copy number at the critical region and tolerates no exper-
imental additions.
The purpose of the present study was to explore the fol-
lowing questions (figure 1):
1. If MCHs carried more than 1 exogenous chr3 copies,
would loss of each supernumerary copy provide the cell
with growth advantage and permit clonal expansion?
2. Would the lost segments necessarily originate from the
transferred normal chr3 or could they also originate from
the endogenous, tumor derived sequences?
3. Is the resistance to copy number change enforced with
equal stringency for different chr3 segments?
The results of our study support the hypothesis of "man-
datory chromosomal segment copy number". Comparing
losses of different chr3 segments, we found that the strin-
gency of copy number maintenance was particularly
strong for 3p14-p21. It is weaker for other 3p regions. In
contrast, the increase in copy number was well tolerated
by 3q26-q27.BMC Cancer 2007, 7:21 http://www.biomedcentral.com/1471-2407/7/21
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Methods
1. Cell lines
MCH A9Hytk3 and MCH 903.1 containing a single
cytogenetically intact human chr3 on mouse fibrosar-
coma A9 background [12,13], were used as chr3 donors
for microcell mediated chromosome transfer as described
[14].
Hygromycin resistance gene tagged chr3 from MCH
A9Hytk3 was transferred into nonpapillary (clear cell)
RCC cell line KH39. Microcell hybrid lines were selected
and propagated in vitro with 400 μg/ml Hygromycin B
(Sigma, St. Louis, MO). MCHs, designated #3/KH39
(YYK2) and Δ3/KH39 (YYK1) were obtained from differ-
ent fusion events [8].
Geneticin resistance gene tagged chr3 from MCH 903.1
was transferred into the poorly differentiated NPC cell
line Hone 1. MCHs were selected and propagated in vitro
with 400 μg/ml Geneticin (G418) (Sigma, St. Louis, MO)
[7]. MCH #3/Hone1 (MCH4.8) was used for the present
study.
Six-week old SCID mice were used for inoculations (106
cells per site). Mice were observed for tumor formation
once a week up to 20 weeks. The tumors were excised
under sterile conditions, explanted and expanded.
2. Fluorescence in Situ Hybridization (FISH)
The slides for FISH were prepared using standard tech-
niques from the cells treated with colcemide, hypotonic
solution and fixed in methanol: acetic acid (3:1).
DNA from CER1 specific PAC RP6-123i13 clone [11] was
isolated using Qiagen columns (QIAGEN, Inc., Hilden,
Germany) and labeled with biotin-dUTP (BIO-Nick
Translation Mix, Roche Molecular Biochemicals, Man-
nheim, Germany). Double color FISH was performed as
described [15] using chr3 specific painting probe labeled
with FITC (Cambio, Cambridge, UK), combined with
biotin labeled RP6-123i13. The biotin-labeled probe
hybridization was detected with Cy3 conjugated streptavi-
din (Amersham Biosciences, GE Healthcare Worldwide).
For analysis of Hone1 derived cells, we applied a second
round of FISH using chr2 and chr12 specific painting
probes labeled with Cy3 and biotin (Cambio, Cambridge,
UK). The biotin-labeled probe hybridization was detected
with Cy5 conjugated streptavidin (Amersham Bio-
sciences, GE Healthcare Worldwide).
A fluorescence microscope (Leitz-DMRB, Leica, Heidel-
berg, Germany) equipped with a Hamamatsu C 4800
cooled CCD camera (Hamamatsu, Herrsching, Germany)
was used to analyze minimum 20 metaphases and mini-
mum 100 nuclei in each sample. For four-probe FISH, we
captured the same metaphases after first and after second
FISH round. Using Adobe Photoshop 7.0 (Adobe Sys-
tems, San Jose, Calif., USA) we superimposed the two
images attributing to different probes different artificial
colors (see figure 2C).
3. Multipoint FISH (mpFISH) for analysis of lost versus 
retained chromosomal fragments
DNAs prepared from chr3 specific plates (2 × 96-deepwell
blocks) of Human FISH confirmed clones collection were
obtained from BACPAC Resources Center (BPRC), CHIL-
Chromosomal changes, expected on the basis of the "TSG loss" and the "mandatory chromosomal segment copy number"  models, respectively Figure 1
Chromosomal changes, expected on the basis of the "TSG loss" and the "mandatory chromosomal segment 
copy number" models, respectively. A. The putative TSG is inactivated in the recipient tumor cell. Following the transfer 
of normal chromosomes, only the loss of exogenous TSG copies would provide the cell with selective growth advantage. B. 
The recipient tumor cell must maintain equilibrium with regard to the total copy number of certain chromosomal segments. 
Transfer of supernumerary chromosomes is followed by the restoration of the original balance by a multi-phase expansion of 
clones, losing first one, then the other extra-copy of the critical regions, irrespectively of their endo- and exogenous origin.BMC Cancer 2007, 7:21 http://www.biomedcentral.com/1471-2407/7/21
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DREN'S HOSPITAL OAKLAND, Oakland, USA. All the
probes or part of them were used in 2-color FISH to ana-
lyze chromosomes in Hone1 and in KH39 based MCHs.
The probes were labeled either with biotin-dUTP or with
digoxigenin-dUTP (BIO-Nick Translation Mix or Digoxi-
genin-Nick Translation Mix, Roche Molecular Biochemi-
cals, Mannheim, Germany). The biotin-labeled probe
hybridization was detected with Cy3 conjugated streptavi-
din (Amersham Biosciences, GE Healthcare Worldwide),
the digoxigenin-labeled probe hybridization – using FITC
conjugated anti-digoxigenin antibodies (Roche Molecular
Biochemicals Mannheim). The presence or absence of sig-
FISH analysis of Hone1 derived cells Figure 2
FISH analysis of Hone1 derived cells. A. Dual-color metaphase FISH (see METHODS) shows that in Hone1, parts of chr3 
detected by chr3 painting probe (green) are included into different marker chromosomes (M1, M2 ...). The four underlined 
markers contain 3p21 as determined using the RP6-123I13 probe (red). B. After chromosome transfer, two additional normal 
chrs3 (N) are detected in #3/HONE1, clone 1. C. Identification of the marker chromosomes by four-probe metaphase FISH 
(see METHODS). Chr2, 3 and 12 painted parts are shown in red, blue and yellow, respectively. 3p21 RP6-123I13 signal is 
green. M1 has a translocation of a part of chr12. M2 carries a chr2 insertion. In M5, chr3 parts are translocated to a chr12 
derived segment. D. Interphase FISH shows six RP6-123I13 probe signals (red) in the majority of the #3/Hone1 nuclei (blue 
DAPI staining). The sample was taken at the zero time point of in vitro propagation. This implies that the sample carries two 
supernumerary copies of the 3p21 (CER1) region, compared to four copies characteristic for Hone1. E. Interphase FISH, using 
the same probe, shows that #3/Hone1 cells have lost two supernumerary 3p21 copies after in vivo growth (tumor 2).BMC Cancer 2007, 7:21 http://www.biomedcentral.com/1471-2407/7/21
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nals on each marker chromosome was analyzed with a
fluorescence microscope equipped with a Hamamatsu C
4800 cooled CCD camera (see details in [16]).
4. Analysis of polymorphic microsatellite markers
Eight polymorphic microsatellite markers within the
3p14.3-21.2, spanning 51–56 Mb, were used to score
LOH: D3S1573, D3S3947, D3S3139, D3S1588,
D3S1289, D3S1613, D3S1606, and D3S3721 [17]. Micro-
satellite analysis was performed by fluorescent PCR-based
analysis on an Applied Biosystems Prism™ 3100 Genetic
Analyzer (Applied Biosystems, Foster City, CA, USA). The
PCR reactions were carried out in 10 μl reaction mix con-
taining 10 × PCR Buffer II, 250 μM dNTP, 2.5 mM MgCl2,
10 pmol of each primer, 0.5 U of AmpliTaq Gold DNA
Polymerase (Applied Biosystems, Foster City, CA, USA), 4
μM F-dCTP (for non-fluorescent labeled primers,
D3S1289 and D3S1606 only) and sterile deionized water.
100 ng genomic DNA was amplified for 30 cycles at 94°C
30 sec, 55°C 30 sec, and 72°C 30 sec on a GeneAmp®
9700 PCR system (Applied Biosystems, Foster City, CA,
USA). PCR products were then injected into semi-auto-
mated ABI Prism™ 3100 Genetic Analyzer for capillary
electrophoresis and analyzed using GeneScan and Geno-
Typer 2.1 software.
Results
1. Detection and analysis of clones by metaphase 
Fluorescence in Situ Hybridization (FISH)
To examine chromosome changes according to the
scheme in figure 1, we have chosen KH39 and Hone1
derived MCHs that contained 2 extra chr3 copies with
intact CER1 and FER regions. We designated them as #3/
KH39 and #3/Hone1. They were previously named YYK2
[8] and MCH4.8 [7], respectively. As controls, we used the
KH39 and Hone1 cell lines and the KH39 derived MCH
that carried one exogenous chr3 with CER1/FER dele-
tions. The latter is called Δ3/KH39 and was previously
named YYK1 [8]. These MCHs were analyzed using dual-
color metaphase FISH with chr3 painting and 3p21 CER1
specific RP6-123i13 probes. For each metaphase we deter-
mined a "chr3 constitution" based on the combination
of normal (N) and abnormal (marker, M1, M2...) chrs3
(figure 2A and 2B). The chromosomes were distinguished
by their morphology and by the presence (underlined, N,
M1, M2...)  or absence (M5, M6 ...) of the 3p21 RP6-
123I13 signal. Dual-color FISH identified 7 markers in
Hone1 derived cells, whereas the detection of the 8th
marker was difficult due to the very small 3q part (4Mb,
according to our Multipoint FISH data). It was also diffi-
cult to distinguish between chromosomes N, M1, M2 and
M5 (figure 2B). In order to define the chr3 constitution of
#3/Hone1 unambiguously, we excluded the 8th marker
from analysis and identified the other markers by four-
probe FISH (figure 2C).
Whenever a given chr3 constitution was found in more
than 10% of the analyzed metaphases in a cell sample, we
regarded these metaphases as belonging to the same cell
clone (c1, c2 ...). The clonal "representation" (% of met-
aphases with a particular chr3 constitution) was deter-
mined in samples taken at 0, 3, 6 and 9 weeks of in vitro
propagation and in Severe Combined Immunodeficiency
(SCID) mice derived tumors (figures 3 and 4). The term
"expanded clone" refers to a clone that appeared at the
given time or its representation was not decreased (ratio
>0.8) compared to the previous time point. The expanded
clones were classified according to the number of 3p21
RP6-123i13 FISH signals per metaphase. This was 4 in
Hone1 and 2 in KH39. Expanded clones with 2, 3 or 4
RP6-123i13 FISH signals in KH39 derived cells and 4, 5 or
6 signals in Hone1 derived cells, were classified as clone
without, with 1 or 2 supernumerary 3p21 copy numbers,
respectively (see orange, yellow or green colors in figures
3 and 4).
2. Clonal changes in #3/Hone1 and #3/KH39
Figures 3 and 4 show changes in clonal representation in
Hone1 and KH39 derived cells observed during a period
of 9 weeks of in vitro propagation and after in vivo growth.
The control KH39 and Hone1 did not show any cytoge-
netic changes. The MCH Δ3/KH39 that had an extra chr3
copy with 3p21 deletions retained its dominant clone
during 9 weeks of in vitro propagation and following in
vivo  growth. In contrast, the MCHs #3/KH39 and #3/
Hone1, which had extra copies of chr3 with intact CER1
and FER, exhibited notable changes. After 3 weeks of cul-
tivation, the clones with 1 supernumerary 3p21 copy (fig-
ure 3D and 4D, yellow) replaced the clones with 2
supernumerary 3p21, which were dominant at week 0
(figure 3C and 4C, green). After 9 weeks, clones that have
lost all supernumerary 3p21 copies, took over (figure 3D
and 4D, orange). This two-step clonal expansion is in line
with the "mandatory chromosomal segment copy
number" hypothesis (see figure 1B). Analysis of the chr3
constitution of different clones that emerged during MCH
propagation shows that they are probably derivatives of
the initial clones. Having growth advantage, they
expanded during propagation. A hypothetical chain of
changes with emergence and expansion of derivative
clones is shown for #3/KH39 in figure 5. The growth
advantage of cells with one supernumerary copy of 3p21
compared to two and with no supernumerary copies com-
pared to one copy was confirmed directly by Bromodeox-
yuridine (BrdU) incorporation into the KH39 derived
MCHs (figure 6).
Clones with one or no supernumerary 3p21 copies
expanded in the in vivo derived #3/KH39 and #3/Hone1
tumors as well (see figures 3E and 4E). Another indication
of the growth and colony formation promoting effect ofBMC Cancer 2007, 7:21 http://www.biomedcentral.com/1471-2407/7/21
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an extra-3p loss was obtained from the single cell colony
analysis of #3/KH39 (figure 4F). Ten largest #3/KH39 sin-
gle cell colonies were picked up and analyzed. Out of
these 10 subclones, 8 did not have supernumerary 3p21
copy. Only 2 had one supernumerary 3p21 copy. No
clones were found with two supernumerary 3p21 copies,
in spite of their overrepresentation in the MCH harvested
to obtain colonies (#3/KH39, time point zero of in vitro
propagation, figure 4C).
Interphase FISH with the RP6-123I13 probe (see figures
2D and 2E) confirmed the results of chromosome analy-
sis. Hone1 and KH39 gave 2 and 4 RP6-123I13 signals,
respectively, in the majority of the nuclei and this propor-
tion did not change during in vitro and in vivo growth. At
the beginning, the prevalent cell population in #3/Hone1
and #3/KH39 contained 6 and 4 copies, respectively, of
3p21. After in vitro propagation of #3/KH39 and #3/
Hone1 during 3 and 6 weeks, respectively, one supernu-
merary 3p21 copy was lost in the majority of cells. After 9
Clonal changes in Hone1 and derived MCH #3/Hone1 Figure 3
Clonal changes in Hone1 and derived MCH #3/Hone1. A. Four-probe FISH determines the chr3 constitution (see 
explanation to figure 2C) for #3/Hone1 samples taken at 9 weeks of in vitro propagation (c4) and in SCID tumor 2 (c5). B. 
Chr3 constitution for each clone. N- normal chr3; red specifies the exogenous chromosome; black are endogenous Hone1 
derived markers, M1, M2 ... M7. Underlined: RP6-123I13 signal is present. C-E. Percentages of metaphases representing a par-
ticular clone at 0, 3, 6 and 9 weeks of propagation and in all SCID tumors analyzed. Orange, yellow and green shading: 
expanded clones with no, 1 and 2 supernumerary 3p21 copies, respectively, compared to Hone1. The term "expanded clone" 
refers to a clone that appeared at the given time or its representation was not decreased (ratio >0.8) compared to the previ-
ous time point. No shading: decreased representation from previous time point. Empty: clone is not present in the sample. 
Note that chr3 fragments, which were carried by N, M1, M2 and M3, were lost in more than one clone expanded during 
growth ("lost chr3 segments"), whereas ones included into M4, M5, M6 and M7 were never lost ("retained chr3 segments").BMC Cancer 2007, 7:21 http://www.biomedcentral.com/1471-2407/7/21
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Clonal changes in KH39, Δ3/KH39 and #3/KH39 Figure 4
Clonal changes in KH39, Δ3/KH39 and #3/KH39. A. Dual-color FISH defines chr3 constitution (see explanation to figure 
2A and 2B) for c7 in the #3/KH39, 9 weeks of in vitro propagation, and for c9 and c10, representing single cell colonies of the 
#3/KH39. Marker chromosomes are shown magnified. Orange text box with clone number (c7, c9): clones without supernu-
merary 3p21 copy. These have two RP6-123I13 signals (red arrows) per metaphase. Yellow text box: clone (c10) with one 
supernumerary 3p21 copy. It shows three RP6-123I13 signals per metaphase. B. Chr3 constitution for each clone includes N 
(cytogenetically normal chr3) and M, M1, M2 ... M7 (different marker chromosomes). Underlined: the present or lost chromo-
some had 3p21 FISH signal. C-F. Percentages of metaphases representing a particular clone at 0, 3 and 9 weeks of propagation; 
in all analyzed SCID tumors and in 10 single cell colonies (not done for KH39 and Δ3/KH39, "nd"). The tumors that derived 
from #3/KH39 and Δ3/KH39 have been analyzed previously [8]. Orange, yellow and green shading: expanded clones with no, 1 
and 2 supernumerary 3p21 copies, respectively, compared to KH39. The term "expanded clone" refers to a clone that 
appeared at the given time or its representation was not decreased (ratio >0.8) compared to the previous time point. No 
shading: decreased representation compared to previous time point. Empty: clone is not present in the sample. Note that chr3 
fragments, which were carried by N and M1, were lost in more than one clone expanded during growth ("lost chr3 segments"), 
whereas ones included into M, M3, M4, M5, M6 and M7 were retained as extra chr3 copies in the expanded clones ("retained 
chr3 segments").BMC Cancer 2007, 7:21 http://www.biomedcentral.com/1471-2407/7/21
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weeks in vitro propagation, the major subpopulation in
both MCHs did not contain any supernumerary 3p21
copy. The same was found after in vivo growth in all #3/
KH39 derived tumors and in 3/5 #3/Hone1 derived
tumors.
3. Rigidity of the initial copy number
Analyzing changes of chr3 constitution during MCHs in
vitro  and in vivo growth, we have found that chromo-
somes, which contained 3p21, were preferentially lost
compared to the chromosomes that did not have it (see
underlined versus not underlined chromosomes in Fig-
ures 3B and 4B). This suggests that the rigidity of the ini-
tial copy number is different for different chromosomal
segments. To examine the tolerance of different chr3
regions to copy number change, we performed Multipoint
FISH (mpFISH) analysis (see METHODS) on the marker
chromosomes. Chromosomes N and M1 were repeatedly
lost in the #3/KH39 derived expanded clones; in the #3/
Hone1 these were N, M1- M3("lost chr3 segments") (see
figures 3 and 4). Markers that were never lost and frag-
ments retained as an extra-copy after in vitro propagation
and in vivo growth, were M in Δ3/KH39; M3-M7 in #3/
KH39 and M4, M5-M7 in #3/Hone1 ("retained chr3 seg-
ments"). The results of mpFISH analysis of the "lost" ver-
sus the "retained chr3 segments" are shown in figure 7B
and 7C (red versus green bars).
The previously reported frequently eliminated region
(FER) at 3p14.3-p21.2 was part of all "lost", but none of
the "retained chr3 segments". This region is most resistant
to copy number gain. In contrast, 3q26.3-q27 was present
preferentially in the "retained chr3 segments" being thus
most tolerant to copy number gain.
To relate our results to previous findings, we looked for
published data concerning chr3 transfer into tumor cells
[7,9,18-23]. The search showed that 3p14.3-p21.2 was
frequently involved in growth suppression (red in Figure
7D), while 3q26.3-q27 was regularly retained after in vivo
growth of mouse fibrosarcoma/human chr3 MCHs
([2,24] and our unpublished data). This region was desig-
nated CRR (Common Retained Region) (green in Figure
7D).
We have also used CGH Case Comparison Tool [25] to
analyze FER and CRR involvement in 510 cases of color-
ectal, renal, parathyroid, lung, pancreas, breast, cervical,
fallopian tube, ovarian, vaginal and tonsil carcinomas
(figure 7E). This search showed that 208 cases had 3q
gains with highest incidence within the CRR. The entire
3p14-p21 region or part of it was lost in 84 cases, 164
cases showed gains on chr3 excluding this region.
4. The consistently lost 3p (FER) region can be of either 
exogenous ("normal") or endogenous ("tumor") origin
Figure 3B shows that the exogenous (red) and the endog-
enous (black) chromosomes could be lost alternatively
during in vitro and in vivo propagation of #3/Hone1. Eight
polymorphic microsatellite markers within and close to
FER were included in the LOH study (figure 8). Hone1
was heterozygous for 6 of 8 markers, suggesting that the
endogenous marker chromosomes contain two alleles for
this region. Further analysis of chr3 donor MCH903.1 and
hybrid #3/Hone1 has proven that both recipient and
donor alleles were present in #3/Hone1. In order to exam-
ine the losses in the tumors we selected two markers,
D3S1588 and D3S1289, with three clearly distinguishable
peaks corresponding to endogenous and exogenous alle-
les. Analysis of 5 tumors did not show complete loss of
any of the alleles. There were reproducible changes in the
Schematic illustration of dual-phase clonal expansion of cells  that lose first one (yellow) then the second (orange) super- numerary 3p21 copy in #3/KH39 MCH propagated in vitro  during 0, 3 and 9 weeks (0w, 3w and 9w, respectively) Figure 5
Schematic illustration of dual-phase clonal expansion 
of cells that lose first one (yellow) then the second 
(orange) supernumerary 3p21 copy in #3/KH39 MCH 
propagated in vitro during 0, 3 and 9 weeks (0w, 3w 
and 9w, respectively). Chr3 constitution and derivation of 
each clone is shown at the top. 3p21 is indicated as a black 
band on 3p. In comparison to KH39, which has 2 copies of 
this region, 4, 3 and 2 copies in a clone correspond to 2, 1 
and no supernumerary copies, respectively. The cells repre-
senting such clones are shown below in green, yellow and 
orange colors, respectively. Clone c5, derived from c2 by a 
chr3 rearrangement (M4), gave rise to c6 by loss of M1. Loss 
of one normal chr3 in c2 led to expansion of c4. Transloca-
tion of the long arm of chromosome 1 (white on M3) to 3q 
in c3 produced clone c7, which expanded as the largest 
clone.BMC Cancer 2007, 7:21 http://www.biomedcentral.com/1471-2407/7/21
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balance between peak sizes however, corresponding to the
cytogenetical finding of the alternative loss of either the
endo- or the exogenous chromosomes.
In #3/KH39 it was impossible to distinguish between exo-
and endogenous chromosomes cytogenetically. On the
basis of comparative cytogenetic and LOH tests we have
reported earlier that the rearrangements could affect either
the exo- or the endogenous chr3 in the #3/KH39 SCID
tumors [8]. In the present study, we found indirect evi-
dence that the endogenous chr3 could be rearranged or
lost in single cell derived colonies. Figure 4B shows that c8
and c9 retained only one N, indicating that at least one
endogenous chr3 was lost or rearranged; c12, had the chr3
constitution NN and was growing in selective medium
(see METHODS). This suggests that at least one of these
chrs3 was exogenous.
The equivalence of endo- and exogenous losses gives
strong support to the idea that the copy number of certain
chr3 segment is strictly controlled and brought back to its
original value by selection, going after chr3 transfer (see
figure 1B).
Discussion
We have previously shown that the transfer of a normal
chr3 into an RCC and a NPC tumor cell lines suppressed
tumorigenicity [7,8]. In vitro/in vivo growth of the derived
intact chr3 carrying MCHs was associated with chr3 losses
and rearrangements. Cell clones that have lost either an
exogenous or an endogenous supernumerary 3p
expanded preferentially. Due to the loss of certain chr3
segments, the original 3p copy number that existed in the
tumor cell prior to the transfer of normal chromosome
was re-established. This indicates that these aneuploid
tumor cells are dependent on a precise balance that they
have evolved with regard to some chromosomal seg-
ments, but not others. The differential sensitivity of chr3
segments to the change of the numerical equilibrium,
seen both in the nearly diploid KH39 and the highly rear-
ranged Hone1 line, is especially interesting (see Figure 7).
The copy number of the FER (3p14.3-p21.2) region was
guarded with particular rigor in both. In contrast, an extra
3q was often retained, even after long propagation. The
copy number of 3q26.3-q27 (CRR) was higher than the
original recipient cell line number in all 9 analyzed in vitro
growth selected clones and in 7 of 8 in vivo selected clones.
The copy number of FER was two in the hyper-diploid
KH39 and 3 in the hypo-tetraploid Hone1 line. Chr3
transfer increased the FER copy number by 2 after chr3
transfer in both cell lines changing this region status from
"loss" (copy number less than ploidy level) to "gain"
(copy number higher than ploidy level). Extra FER copies
were eliminated during in vitro propagation and in vivo
passage from both MCHs although at a different rate.
Even after long propagation, one additional 3p copy was
detected in a fraction of cells in the #3/Hone1 (see Figure
The S-phase fraction of cells increases with loss of an extra 3p21 copy Figure 6
The S-phase fraction of cells increases with loss of an extra 3p21 copy. Living cells of the MCHs #3/KH3 and Δ3/
KH39 were incubated with BrdU in final concentration 30 μg/ml during 1 hour followed by fixation with methanol: acetic acid 
(3:1). FISH with biotin-labeled 3p21-specific RP6-123i13 probe and centromere-specific probe was performed to analyze the 
#3/KH3 and the Δ3/KH39 respectively. The probe signal was developed using Cy3-conjugated streptavidin (red), while FITC-
conjugated anti BrdU antibodies (Roche Molecular Biochemicals Mannheim, Germany) identified cells in S-phase (green). Per-
centage of S-phase cells in subpopulations of cells with different 3p21 copy numbers in the #3/KH39 and with different chr3 
copy number (counted by number of centromeres) in the Δ3/KH39 was calculated in more than 100 nuclei. The calculation 
was repeated three times when number of cells allowed. The average values and standard deviations are shown.BMC Cancer 2007, 7:21 http://www.biomedcentral.com/1471-2407/7/21
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3), but not in the #3/KH39 (see Figure 4). This is consist-
ent with the "lower gain" of FER by one copy number
increase in #3/Hone1 (4 copies in hypo-tetraploid cell
line) compared to #3/KH39 (3 copies in hyper-diploid
cell line).
Several studies show that introduction of exogenous DNA
into cultured tumour cells leads to chromosomal instabil-
ity, disturbing the gene equilibrium [26]. An alternative
hypothesis for restoration of tumourigenicity could then
involve other mechanisms, than loss of 3p, like gain or
loss of other chromosomes. Multiplex FISH (M-FISH)
analysis of #3/KH39 MCHs showed, that other chromo-
somes were rearranged during the propagation of the
MCHs as well [6]. The involved chromosomes were regu-
larly polysomic (present originally in more than 2 copies)
Variation in the rigidity of initial copy number in different chr3 segments Figure 7
Variation in the rigidity of initial copy number in different chr3 segments. A. Chr3 ideogram with the localization of 
FER and CRR regions (empty horizontal bars through the figure). B-C. Analysis of the genetic material of the expanded clones 
shows that elimination of the "lost chr3 segments" in contrast to the "retained chr3 segments" was associated with growth 
advantage (see figures 3 and 4). Therefore we compare these "lost chr3 segments" (red vertical bars) with the "retained chr3 
segments" (green vertical bars) in order to find a "mandatory copy number region. MpFISH identified chr3 regions that are 
present on the "lost" (red) and the "retained segments" (green) in KH39 and Hone1 derived MCHs (see figures 3 and 4) (gray: 
the region was not analyzed). D. Summary of data concerning the regions involved in growth suppression following chr3 trans-
fer into tumor cell lines, as reported at the time of publication. Note that many of the early MMCT studies were limited by 
availability of genetic markers for assaying content of hybrids or were not performed comprehensively to include genetic 
marker analysis of both chromosome arms. Red: reported regions associated with the growth suppression: (1) in ovarian car-
cinoma line HEY [19]. (2) in breast carcinoma line 21NT [22]; (3) in RCC cell line RCC23 [20]; (4) in RCC cell line KC12 [21]; 
(5) and (6) in mouse fibrosarcoma A9 cell line [18] and [9]; (7) in NPC Hone1 cell line [7]; (8) in esophageal squamous cell car-
cinoma cell line SLMT-1 [23]. Green: common retained region (CRR) tends to persist in mouse fibrosarcoma A9/human chr3 
MCHs after 4 consecutive passages through SCID mice. (9) [24]; (10) the region was reduced to the segment between PCR 
markers D3S1282 (3q26.2) and D3S1262 (3q27.3) (our unpublished data). E. Data about losses and gains of chr3 segments in 
510 cases of colorectal, renal, parathyroid, lung, pancreas, breast, cervical, fallopian tube, ovarian, vaginal and tonsil carcinomas 
reported in NCBI SKY/M-FISH and CGH Database [25]. Each red line corresponds to the loss, each green – to the gain of the 
segment in a particular tumor sample.BMC Cancer 2007, 7:21 http://www.biomedcentral.com/1471-2407/7/21
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and served as partners for unbalanced chr3 translocation.
This led us to conclude that polysomy is associated with
structural chromosome instability [6]. The recurrent
involvement of chr3 and the differential involvement of
3p and 3q were obvious in our previous and present stud-
ies. This selectivity of the loss indicates that both, the
induction of instability by MMCT and the selection for
specific 3p/3q balance, take place in the MCHs.
Several tumor growth inhibiting genes are known to
reside on 3p [1,2]. This may explain the tendency of the
entire 3p to equilibrate at a low copy number (see Figure
7). The known TSG, FHIT (fragile histidine triad) at 3p14
[27] centromeric to FER, was only found in one copy in
the hypo-tetraploid Hone1. Interstitial deletions within
this gene were detected on two marker chromosomes M2
and M3 in Hone1. After in vitro propagation of #3/Hone1,
both M2 and M3 were eliminated with the same fre-
quency as the normal chrs3 and M1, which had an intact
FHIT (c3, c4, c5 and c6 in Figure 3). However, after in vivo
growth, the normal chr3 and M1 were lost more fre-
quently than the other markers (c2 and c5 represent 20%
and 40% of in vivo tumor cells, respectively, in Figure 3).
FHIT mRNA was expressed in KH39 and in the derived
hybrids whereas the protein level was slightly decreased
after in vivo growth (our unpublished data). This suggests
that the dependence of the tumor on a correct FER copy
number is stronger than what can be attributed to FHIT.
Still the FHIT  copy number may have an additional
impact in vivo. Telomeric to FER a lung cancer TSG region
(LUCA) was reported to contain multiple potential TSGs.
This region is frequently affected by deletions in lung and
other epithelial cancers. Several genes located here
showed reduced mRNA levels in lung cancer cell lines and
for some of these additional functional data supported
their role as TSGs. None of the candidate TSGs
(CACNA2D2, PL6, 101F6, NPRL2, BLU, RASSF1, FUS1,
HYAL2, HYAL1 and SEMA3B) showed a frequent muta-
tion rate in lung cancer samples however, suggesting that
they may function in dose-dependent manner (see [1] for
review). Earlier we have examined the expression of 34
human 3p-genes from known cancer-related regions
including LUCA in mouse fibrosarcoma A9 based MCHs
and derived tumors. We have found the transcript of the
solute carrier family 38 member 3 gene (SLC38A3) was
not found in 8 tumors and was greatly reduced in 1 out of
these 9 tumors. Transcription of this gene was also
impaired in 5 RCC cell lines analyzed [28]. However, the
LUCA region does not overlap our "mandatory copy
number region". It was present in supernumerary copes in
Δ3/KH39, which grew without any losses. The genes from
this region did not change their expression in the KH39
derived MCHs (our unpublished data). In #3/Hone1 the
region was present on M4 marker chromosome, which
was never lost in the expanded clones (see figure 3). In
summary, there are probably several genes on 3p, which
are preferred at low copy numbers in a tumor. As conse-
quence, the tumor is dependent on its gene copy number
balance, but for some genes the quantitative rigidity is
stronger than for others. FER is an example of a "manda-
tory copy number region".
The tolerance of CRR to copy number gain may be due to
the presence of growth promoting genes. It was preferen-
Polymorphic microsatellite marker analysis of Hone1, #3/ Hone1 and 5 derived tumors Figure 8
Polymorphic microsatellite marker analysis of 
Hone1, #3/Hone1 and 5 derived tumors. PCR products 
of genomic DNA amplification using 2 polymorphic microsat-
ellite markers D3S1588 and D3S1289, located within 3p21.1 
(54.1 Mb) and 3p14.3 (54.5 Mb), respectively, were analyzed 
using semi-automated ABI Prism™ 3100 Genetic Analyzer 
for capillary electrophoresis. The results are presented in 
graphical view according to GeneScan and GenoTyper 2.1 
software. Recipient Hone1, donor MCH903.1, hybrid #3/
Hone1 and 5 tumors derived from the #3/Hone1 were geno-
typed. Horizontal lines above the peaks show the original 
ratio between peak heights (characteristic for the #3/
Hone1). Arrows indicate relative reduction of endogenous 
(derived from Hone1) peaks in the tumor compared to the 
#3/Hone1 used for SCID mice inoculations. This reduction 
was detected for both markers in two independent experi-
ments.BMC Cancer 2007, 7:21 http://www.biomedcentral.com/1471-2407/7/21
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tially retained in our earlier studies on a mouse tumor
MCH system [9]. Gains on 3q are frequently detected in
human tumors. NCBI SKY/M-FISH and CGH Database
analysis [25] shows that in different carcinomas the fre-
quency of gains affected 3q26 and 3p21-pter was highest
and lowest, respectively (see figure 7D). Interestingly, no
3p21 gain was found in 98 cases of such carcinoma types
as fallopian tube, kidney, parathyroid, lung and breast
carcinomas. This was the only autosomal region that
retained the same "no gain" copy number in all 98 cases.
When we analyzed 10 RCC cell lines, no FER gain was
found in spite of centromere gain in 5 and 3q26-qter gain
in 8 of the 10 cell lines (data not shown). Seven of these
had FER deletions, but only three of the seven cell lines
showed LOH for polymorphic microsatellite markers in
FER [see Additional file 1]. This suggests that 3p deletions
may occur preferentially when chr3 is polysomic (more
than 2 copies) and could act by copy number reduction.
Taken together, these findings affirm the notion that the
copy number restriction at specific chromosomal seg-
ments, exemplified by 3p14-p21, is critically important
for tumor growth. In contrast, copy number gain in 3q26-
q27 is positively associated with tumor growth. This
apparent disequilibrium can be readily achieved in aneu-
ploid cells, e.g. by the structural instability of polysomic
chromosomes, with breakage within late replicating
regions of supernumerary chr3, often close to the centro-
mere [6]. Translocations of 3q fragments would result in
the loss of supernumerary 3p and retention of 3q, gener-
ating the optimal balance of chr3 segment copy numbers
for the given tumor line.
Conclusion
Short arm of human chr3 shows frequent losses in human
carcinomas, in contrast to long arm that is affected by
gains and amplifications. The regions 3p21 and 3q26 are
often involved in those reciprocal changes. Our earlier
studies with MCHs, generated by the introduction of a
normal human chr3 into murine or human tumor cells
have already led to the notion, that 3p may contain tumor
growth antagonizing and 3q – growth promoting genes.
Following tumor growth in SCID mice, MCHs regularly
lost defined regions in the 3p14-p21 area, designated as
CER1 and FER. In contrast, 3q26-qter (CRR) was main-
tained even after serial mouse tumor passages.
In this paper, we showed that the in vitro and in vivo losses
affecting the 3p14.3-p21.2 (FER) segment in tumor cells
with an introduced exogenous normal human chr3 may
alternatively target the exogenous or an endogenous chr3.
This shows a dosage effect and speaks against any qualita-
tive, e.g. mutational inequality between the tumor derived
and the normal chromosome. The intolerance to this dos-
age change does not apply to 3q where the increased copy
number is readily maintained and apparently favored.
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